Table 4.
Critical care interventions and outcomes of the cohort assessed by NIPPV failure status.
| Entire cohortn=153 | NIPPV failuren=97 | NIPPV successn=56 | p-value | |
|---|---|---|---|---|
| Length of vasoactive use (days) | 2.0 (0.8, 8.1) | 1.9 (0.7, 11.2) | 3.1 (1.0, 6.3) | 0.846 |
| CRRT at any time in PICU | 41 (27.0) | 37 (38.1) | 4 (7.3) | <0.0001 |
| Length of CRRT (days) | 8.5 (3.3, 15.9) | 9.1 (2.4, 15.9) | 4.1 (3.8, 14.6) | 0.777 |
| Length of PICU stay (days) | 10.0 (4.0, 26.0) | 18.0 (7.0, 35.0) | 4.0 (3.0, 7.0) | <.0001 |
| Length of NIPPV (days) | 1.0 (0.4, 3.5) | 0.7 (0.2, 2.3) | 2.1 (0.8, 4.0) | 0.0004 |
| Length of invasive mechanical ventilation (days) | 6.8 (3.0, 17.5) | 6.8 (3.0, 17.5) | n/a | n/a |
| CPR | 26 (17.5) | 26 (27.7) | 0 (0) | <.0001 |
| PICU survival | 83 (54.6) | 32 (33.0) | 51 (92.7) | <.0001 |
| Hospital survival | 66 (43.1) | 27 (27.8) | 39 (69.6) | <.0001 |
Values are medians (IQRs) for continuous variables and frequencies (percentages) for categorical variables, with p-values from Wilcoxon Rank Sum and Chi-Square (Fisher’s Exact when cell counts were small) tests, respectively.
NIPPV, noninvasive positive pressure ventilation; CRRT, Continuous renal replacement therapy; PICU, Pediatric intensive care unit; CPR, cardiopulmonary resuscitation.